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Introduction 
•  Alzheimer’s Disease (AD) and Osteoporosis are common 
degenerative diseases of aging. Previous research has found 
that AD and osteoporosis may overlap [4].  
•  Observational studies demonstrate a correlation between the 
osteoporosis and AD that suggest, rather than one condition 
causing the other, both conditions are related by a common 
underlying mechanism [4]. 
•  Previous studies have investigated bone mass in mouse models 
that recapitulate the pathology of AD [4].  
•  This study focuses on the 5xFAD mouse model, another AD 
mouse model that exhibits a more aggressive form of AD. 
Thus, the 5xFAD mouse model rapidly recapitulates major 
features of AD amyloid pathway: rapidly accumulating Aβ42 
in the brain, early amyloid deposition and gliosis, robust 
intraneuronal Aβ labeling, neurodegeneration and neuron loss.  
•  The goal of this study was to investigate the skeleton of the 
5xFAD mice and compare its bone density to age-matched 
healthy control mice. 
	
5xFAD and Wild-Type (Control) Mice Tissues 
The 5xFAD mouse model is a validated model of familial Alzheimer’s 
disease. 
Micro-Computed Tomography (µCT) 
The right femur of the wild-type (control) mice and 5xFAD mice were 
scanned and analyzed using µCT. Trabecular bone architecture was 
measured in a proximal region. Primary trabecular parameters included 
bone volume per total volume (BV/TV). Cortical geometry was measured 
in a 100 slice region at the midshaft at 50% of the total length of the femur. 
Primary cortical parameter includes cortical area (mm2).   
Bone Histological Analysis: 
After µCT scanning, the bones were prepared for histological investigation 
by dehydration and decalcification of the femoral tissues. After all the 
calcium from bones were removed, samples were embedded in paraffin, 
cut into sections and mounted for tartrate-resistant acid phosphatase 
(TRAP) and Sudan Black B staining.  
Material and Methods 
Figure 1: X-ray scan of the Femurs. 	
The left image displays an X-ray of a 
Wild-Type mice femur. The right image 
displays an X-ray of a 5xFAD transgenic 
mice femur. 	
Figure 2: Trabecular Bone Volume per 
Total Volume (BV/TV) Comparison. 
Figure 3: Trabecular Bone Volume per Total 
Volume (BV/TV) Comparison. 	
Results and Discussion 
Figure 4: 3D Reconstruction of µCT Scanned Trabecular Bone. 
	
Figure 5: Cortical Area of Femur Bone 
	
Figure 6: Cortical Area of Femur Bone 
	
Figure 7: Tartrate Resistant Acid 
Phosphatase (TRAP) Staining for 
Osteoclasts. 
Figure 8: Sudan Black B 
(SBB) senescence Staining. 
	
Trabecular Bone 
Male 5xFAD mice exhibit a decrease in 
trabecular bone density over time in 
contrast to Wild-Type (WT) mice 
(Figure 3). Older female 5xFAD mice 
exhibit a lower trabecular bone density 









•  The data suggest that 5xFAD mouse model 
recapitulates the low bone mass 
characteristics of osteoporosis 
•  The change in bone density over time 
observed in the 5xFAD mice suggest that the 
bone mass loss is progressive 
•  The data and images collected from the study 
provide evidence to suggest that the 
combination of mutations in the diseased 
5xFAD mice have an effect on the bone 
resorption of the trabecular bone in the 
5xFAD mice in comparison to the WT mice 
(Figure 1,4). 
•  Male 5xFAD mice do not experience cortical 
bone resorption to the same extent observed 
in female mice (Figure 5, 6). 
 
Conclusion and Future Work  
•  We are currently 
performing TRAP 
staining, which is a 
method to identify 
active osteoclasts.  
•  Considering other mouse models that recapitulate AD 
exhibit similar effects in trabecular and cortical bone, our 
current model could share the same mechanisms and 
pathologies that are driving the effects seen in those mouse 
models. Future work is necessary to identify the role of Aβ 
and RANKL Pathway  in the 5xFAD model.  
•  We are also performing Sudan 
Black staining to investigate 
senescence, a process known 
to occur in the brains of AD 
patients, to understand 
whether the bone resorption is 
due to cellular aging.		
•  Bone	loss	has	not	been	studied	nor	published	before	in	
the	5xFAD	model.	Although	AD	and	osteoporosis	are	not	
commonly	considered	linked	diseases,	past	research	
presents	compelling	informa1on	that	they	are	
interconnected.	Con1nuing	to	inves1gate	the	AD	mouse	
models	to	is	crucial	to	further	our	understanding	of	these	
two	devasta1ng	diseases	of	aging.	
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